CNTG

Centogene NV (CNTG)

Centogene NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CNTG

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/01	05 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/06/01	05 : 30	GlobeNewswire Inc.	CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting	NASDAQ:CNTG	Centogene NV
2024/05/29	20 : 32	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/05/17	20 : 20	Edgar (US Regulatory)	Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).	NASDAQ:CNTG	Centogene NV
2024/05/16	06 : 17	GlobeNewswire Inc.	CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:CNTG	Centogene NV
2024/05/16	06 : 12	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:CNTG	Centogene NV
2024/05/16	06 : 10	GlobeNewswire Inc.	CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position	NASDAQ:CNTG	Centogene NV
2024/05/16	06 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/05/16	05 : 56	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/05/14	21 : 30	GlobeNewswire Inc.	CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease	NASDAQ:CNTG	Centogene NV
2024/05/14	21 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/05/10	19 : 30	GlobeNewswire Inc.	CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	NASDAQ:CNTG	Centogene NV
2024/05/10	19 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/04/03	05 : 30	GlobeNewswire Inc.	CENTOGENE Receives Nasdaq Non-Compliance Notice	NASDAQ:CNTG	Centogene NV
2024/03/19	19 : 30	GlobeNewswire Inc.	CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders	NASDAQ:CNTG	Centogene NV
2024/03/01	07 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/03/01	07 : 00	GlobeNewswire Inc.	CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency	NASDAQ:CNTG	Centogene NV
2024/02/28	20 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/02/28	20 : 30	GlobeNewswire Inc.	CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing	NASDAQ:CNTG	Centogene NV
2024/02/28	20 : 30	GlobeNewswire Inc.	CENTOGENE Explores Strategic Alternatives	NASDAQ:CNTG	Centogene NV
2024/02/28	20 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/01/25	20 : 30	GlobeNewswire Inc.	CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration	NASDAQ:CNTG	Centogene NV
2024/01/25	20 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/01/24	20 : 30	GlobeNewswire Inc.	CENTOGENE Receives French Research Tax Credit Accreditation	NASDAQ:CNTG	Centogene NV
2024/01/24	20 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/01/23	20 : 36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/01/23	20 : 30	GlobeNewswire Inc.	CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics	NASDAQ:CNTG	Centogene NV
2024/01/18	21 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
2024/01/18	20 : 30	GlobeNewswire Inc.	CENTOGENE Announces Preliminary Full Year 2023 Revenue	NASDAQ:CNTG	Centogene NV
2023/12/19	21 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV